PharmaSources.com平臺制藥行業(yè)原創(chuàng)內容電子匯編——《Pharma Sources Insight》第三期上線了！
2020年，在全球抗疫的背景下，制藥行業(yè)在研發(fā)新冠**及治療方案等各方面都取得了突破性的進展。與此同時，疫情的發(fā)展影響到了全球制藥行業(yè)從原料藥生產、創(chuàng)新藥研發(fā)乃至制藥物流供應鏈的各個方面。本期Pharma Sources Insight旨在介紹2020年中國制藥行業(yè)在原料藥、腫瘤藥物研發(fā)、基因工程及智能制造等領域的新趨勢及藥企研發(fā)進展，盤點國內制藥行業(yè)重要領域的發(fā)展現(xiàn)狀。
12月16日-18日，制藥工業(yè)壓軸盛會--CPhI & P-MEC China 2020展會將于上海新國際博覽中心隆重舉行。本期Pharma Sources Insight采訪到其中3家優(yōu)質參展商、他們同時也是PharmaSources.com線上平臺會員，分別是：
派亞集團旗下的淄博程明化工設備有限公司
Shandong Charming Chemical Equipment Co., Ltd. under Pioneer Group
漢瑞藥業(yè)（荊門）有限公司
Hiray pharmaceutical（Jingmen）Co.,LTD
上海飛瑞國際貨運代理有限公司
InterMax Logistics Solution Limited
在“Brand Story”品牌故事欄目中，他們將介紹各自企業(yè)的優(yōu)勢及特色產品，分享其在抗疫過程中如何克服重重困難，為客戶提供解決方案的故事。
《Pharma Sources Insight》致力于為制藥行業(yè)經歷的每個重要亮點書寫新的篇章。2020年，Pharma Sources Insight共推出了三期，主題分別為后疫情時代（Post-pandemic Future）、療愈的征程(The Great Journey of Recovery)及制藥中國說(The Pharma Landscape in China)，收獲了制藥人的喜愛與支持。
因為有了讀者的鼓勵，作為制藥全產業(yè)鏈線上服務平臺--制藥在線（CPhI.CN）的國際站，PharmaSources.com將繼續(xù)秉持原創(chuàng)宗旨，攜旗下資深的海外專家撰稿人，為全球制藥人士帶來更多專業(yè)深度的優(yōu)質內容。我們會繼續(xù)努力，敬請期待！
掃碼開始閱讀
Scan to view the full contents.
Pharma Sources Insight
Your FREE source of news and insights into China pharmaceutical industry
Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with those among the leading drug-manufacturers in China which further affect the world.
Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.
Contents：
Pharma Sources Insight October 2020 focuses on the following topics:
PHARMA IN CHINA
- Trends in China’s Pharmaceutical Industry in 2020
- Chinese APIs and Their Role in the World’s Pharmaceutical Industry
- Chinese Pharma Firms Can Support Africa Reduce Import Bill
- Insights Into the Oncology Landscape in China
- The Impact of the Human Genome Project on China Pharmaceutical Industry 20 Years Later
- A Comparison of Top Ten Best-Selling Oncology Drugs in China and the U.S. in 2019
- Which Will Go Further? Innovent or Junshi?
- Production Applications of Chinese New Drugs in 2020 H1: Five Class 1 New Chemical Drugs, Two Anti-PD-1 Monoclonal Antibodies and Two CAR T-Cell Products Applied for Production for the First Time
Brand Story
- PIONEER SPEED - Charming Fully Support All the Pharmaceutical Companies to Fight Against COVID-19
- Hiray Pharmaceutical, API CDMO and Antiviral API R&D Center
- An Opportunity for Pharmaceuticals Logistics During the Special Period : Cold Chain Rail Transport
Industry Insight
- A Smarter Pharma Industry: The Key to Addressing Challenges During the COVID-19 Pandemic
Previous Review
第一期 https://flbook.com.cn/c/5GrJTeke2j
合作咨詢
肖女士
021-33392297
Kelly.Xiao@imsinoexpo.com
2006-2025 上海博華國際展覽有限公司版權所有（保留一切權利）
滬ICP備05034851號-57
